Moderna filed S-1 with SEC last Friday and will become the largest biotech IPO in history.
The record amount of raise ($500 million in current version of documents; I will expect more) just surpassed $421 million (HK$3.3bn) IPO by Innovent. In the past years, the typical size of the largest biotech IPO is around $200-300 million.
Since October, we have seen a series of large biotech IPOs that might also contribute to the money pulled from other biotech companies.
Here is the list of ever-increase IPOs in size since October:
– Guardant Health $238 million
– Allogene $324 million
– Innovent (in HK) $421 million
– Moderna (proposed) $500 million